Healthcare -
Medical - Care Facilities - NASDAQ - US
$ 0.1212
9.19 %
$ 587 M
Market Cap
None
P/E
1. INTRINSIC VALUE
Balance Sheet
Talkspace, Inc.
| Current Assets | 130 M |
| Cash & Short-Term Investments | 118 M |
| Receivables | 9.64 M |
| Other Current Assets | 2.73 M |
| Non-Current Assets | 8.5 M |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 8.5 M |
| Current Liabilities | 19 M |
| Accounts Payable | 7.71 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 11.3 M |
| Non-Current Liabilities | 2.26 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 2.26 M |
EFFICIENCY
Earnings Waterfall
Talkspace, Inc.
| Revenue | 188 M |
| Cost Of Revenue | 102 M |
| Gross Profit | 85.8 M |
| Operating Expenses | 90.3 M |
| Operating Income | -4.5 M |
| Other Expenses | -5.64 M |
| Net Income | 1.15 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Talkspace, Inc.
| Net Income | 1.15 M |
| Depreciation & Amortization | 859 K |
| Capital Expenditures | -5.44 M |
| Stock-Based Compensation | 9.17 M |
| Change in Working Capital | 895 K |
| Others | -1.61 M |
| Free Cash Flow | 6.26 M |
Wall Street Analysts Price Targets
Talkspace, Inc.
TALKW has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
TALKW does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Talkspace, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
8. Profile
Summary
Talkspace, Inc. TALKW
COUNTRY
US
INDUSTRY
Medical - Care Facilities
MARKET CAP
$ 587 M
Dividend Yield
0.00%
Description
Talkspace, Inc. engages in the operation and development of a technology platform used in connecting patients to licensed mental health professionals through messaging, video, and audio. The company was founded by Frank Roni and Frank Oren in 2012 and is headquartered in New York, NY.
Contact
New York, DE,
http://www.talkspace.com
IPO
Date
None
Employees
339
Officers
Dr. Jon R. Cohen M.D.
Chief Executive Officer & Director
Mr. Gil Margolin
Chief Technology Officer
Mr. Michael Lovell
Senior Director of Investor Relations
Ms. Katelyn Watson
Chief Marketing Officer
Dr. Varun Choudhary DFAPA, M.A., M.D.
Chief Medical Officer
Jeannine Feyen
Director of Communications
Ms. Andrea Cooper
Chief People Officer
Ms. Jennifer Fulk
Chief Financial Officer
Mr. John Charles Reilly
Gen. Counsel & Corporation Sec.
Ms. Michaela Yule
Chief Strategy Officer